LOGO  
  Home Site Map
Home Sitemap
Sabinsa Cosmetics LactoSpore Curcumin C3 Complex
Font Increase Font Decrease
      About Us Products Newsroom Contact Us
 
About Us
 
 
Milestones
2015 :
Sabinsa’s LactoSpore® Human Safety Study Cleared for Health Canada Access.
Sabinsa Patent Infringement Litigation Against Prakruti Settled: Curcumin C3 Complex® Patent Successfully Defended.
Sabinsa Launches New, Nano-Free Water Soluble Curcumin Form: uC3 Clear.
Sami Labs Recognized With Two State Export Excellence Awards By Visvesvaraya Trade Promotion Centre, Karnataka, India.
Sabinsa Once More Successfully Protects Curcumin C3 Complex® Patent Infringement Litigation Against Herbakraft Settled.
Sabinsa Awarded Four New Us Patents: Patent Portfolio Total Climbs To 95.
Sabinsa Expands Herb Cultivation Program Founder Promotes Sustainability, Advocates Cultivation To Protect India’s Herbal Legacy.
Sabinsa’s Curcumin C3 Complex® Shows Significant Benefits In Lipid Levels In Patients With Coronary Artery Disease.
UK Study Shows Sabinsa’s Curcumin® C3 Complex To Be Safe Adjunct To, And Enhance Efficacy Of, Folfox Chemotherapy.
Sabinsa / Sami Labs Recognized With Award For Export Excellence By Karnataka Chamber Of Commerce.
Sabinsa’s Utah Facility Receives Foreign Site Registration Number From Canada.
Shaheen Majeed Appointed To Sami Labs Group Board of Directors.
Sabinsa Again Honored With Two Pharmexcil Awards Noting Excellence In Patents And Exports.
Curry Powder To Clinical Significance: New Book Provides a Comprehensive Understanding of Curcumin & Studies on Curcumin C3 Complex®.
Sabinsa Victorious In Litigation Against Nutribiolink For Curcumin C3 Complex® Patent Infringement.
2014 :
Sabinsa adds four new patents, bringing world wide portfolio to 91.
C3 Reduct® wins Functional ingredients editors’ choice award for best science.
Sami and Sabinsa receive Best New Product Excellence Award in the Raw Material category at Panacea-Natural Product Expo India for Saberry®.
Sabinsa / Sami Labs entered into a Memorandum of Understanding with India’s Ayurvedic research organization, Arya Vaidya Sala, Kottakkal (AVS).
Sabinsa / Sami Labs receives two Pharmexcil Awards for 2012 – 2013 in the Herbals, Ayurveda & Nutraceuticals category: the Gold Award for Patents and the Silver Award for Exports in Herbals.
Former President of India visits Sami Labs (late A.P.J. Abdul Kalam).
Sabinsa Introduces new form of coleus with ForsLean® Soft Extract.
Study shows Boswellia® cream may provide relief for psoriasis.
Sabinsa initiates lawsuit against four companies for C3 Complex® patent infringement.
Iranian clinical study shows combination of C3 Complex® and BioPerine® offer relief for osteoarthritis patients.
Sabinsa launches animal nutrition division: VetVitals®.
Sabinsa’s C3 Complex® shown in study to benefit metabolic syndrome.
Sabinsa/Sami Labs acquires KCP Biotech, expands capacity and adds more colors.
Sabinsa teams up with Fruit D’Or to launch LactoSpore®-Cranberry combination LactoCran.
Sabinsa’s LactoSpore® moves into cosmeceuticals with topical Candida products.
2013 :
Next Generation of Curcumin Launched, Resolving Potency, Color, Dosage, Stability and Bioavailability Concerns, called Curcumin C3 Reduct®.
Recipient of Frost & Sullivan’s 2013 North American Integrated Prebiotic Delivery Technology Innovation Award.
United States Patent Granted On A Unique Weight Management Formula.
United States Patent Granted For A Natural Preservative, SabiLize®.
Sabinsa Utah Facility Earns NSF Good Manufacturing Practices (GMP) Registration.
Sabinsa on Wheels Returns to USA, Three Major States Selected and Presented At Utah, California, and New Jersey.
Sabinsa’s Curcumin Receives GRAS No Comment Letter From FDA.
Sabinsa's Sami Labs Named Product Innovator Of The Year.
Sabinsa's LactoSpore® Inspires Gluten-Free Expert To Create Gourmet Cookies.
Sabinsa Launches D'Cosmix Range Of Dermaceutical Composites At International Exhibitions.
Sabinsa Breaks Ground On Additional Facility, Increasing Production 200%.
2012 :
Curcumin C3 Complex® Wins Functional Ingredients Editor's Choice Award in the Marketing Category.
LactoSpore® Chosen For Tutti Frutti, World's Top Selling Self-Serve Frozen Yogurt.
The first non-diary use of Sabinsa’s Shelf-Stable Probiotic, LactoSpore®, can be found in Colombia’s Perman Bread.
New Study Says Sabinsa's Curcumin C3 Complex® Shows Significant Reduction In Serum Triglycerides.
Sabinsa Publishes Book On Tetrahydrocurcuminoids.
Sabinsa On Wheels Held for the First Time in Seoul, South Korea.
Sabinsa Wins Patent In Japan For Coleus Derived Glaucoma Treatment Product.
2011 :
Sabinsa Introduces Integrated Nutritional Composites.
Sabinsa's BioPerine® Validated in Resveratrol Pre-Clinical Study.
Sabinsa Opens Office in South Korea.
Sabinsa Receives Top Pharmexcil Award.
Sabinsa R&D Named Best Innovation and Technology Company by FICCI.
2010 :
Sami's Kunigal plant near Bangalore India received NSF (National Sanitation Foundation) GMP Certification.
Received the first Patent in China for "Process For Preparing Water Soluble Diterpenes And Their Applications".
Sami Labs inks an agreement with CIPLA to market its drug, Sornip for Psoriasis in Indian Market.
Sami's Kunigal plant near Bangalore, India received Bureau Veritas ISO 22000 Certification.
2009 :
Sabinsa received the 2009 Herbal Industry Leader Award from the American Herbal Products Association.
Sabinsa received its 57th patent and it is the First patent from Russia.
2008 :
NABL accreditation for Laboratories of Sami Labs Limited.
Continuous Extraction plant commissioned by Sami Labs Limited in Bangalore.
2007 :
Sabinsa sets up its office in South Africa.
2006 :
Forskolin Eye Drops approved by DCGI for Glaucoma.
Sabinsa Europe GmBH was set up in Langen, near Frankfurt in Germany.
2005 :
Received two patents for Tetrahydropiperine.
Received the second Thomas Alva Edison Patent Award for 2005.
2004 :
Sabinsa's US Patent for ForsLean® received the Thomas Alva Edison Patent Award for 2004.
Dr. Majeed was conferred the Ellis Island Medal of Honor by the National Ethnic Coalition of Organizations (NECO)
2003 :
MGP Herbal (P) Ltd was acquired to facilitate and co-ordinate Herbal Cultivation - a major step that helped provide jobs to several farmers in India.
2002 :
Super-Critical Fluid Extraction facility set up at Nelamangala.
The R&D Centre of Sami Labs Limited, Bangalore received the DSIR Award for its R&D efforts.
2001 :
The anti-obesity product Forslean® was voted as the Best New Product of the year by Nutraceutical Industry Association – Nutracon in the US.
Sabinsa received its first European patent on Curcuminoids.
Sabinsa Japan Corporation was started.
2000 :
Biotechnology Center established at Nelamangala, Bangalore.
Tetrahydrocurcuminoids, also referred to as “White Curcumin” was introduced as a skin lightener into the US market.
1998 :
Sami Chemicals and Extract Pvt. Ltd. – name was changed to Sami Labs Limited to reflect more accurately its current activities.
1997 :
New Jersey Technology Fast 50 Award.
Sabinsa listed again in the Inc 500 companies, ranking # 90.
Award for Export Performance for Spice products from President of India.
1996 :
Sabinsa was listed in the Inc 500 companies, ranking # 70.
First US patent awarded for the product Bioperine® was awarded to Sabinsa Corporation.
An Export-Oriented manufacturing unit is established at Kunigal, Bangalore.
1995-1993 :
Standardization of Indian herbal medicines by Sami research group.
Sabinsa started the “Sabinsa on Wheels” program also know as SOW. Here the Sabinsa team endeavors to share its knowledge to a large group of professionals and common man on its diverse range of products.
1991 :
Sami Chemicals and Extracts Pvt Ltd set up in Bangalore.
1988 :
Sabinsa Corporation, New Jersey USA was setup.
 
 
Last Updated: May 11, 2016 Copyright © Sabinsa Corporation. All Rights Reserved | Privacy Policy | Terms Of Use Powered by Edkal